Recent Blog Postings
- Lupus Foundation of America Honors Prestigious Lupus Research Awardees at the Evelyn V. Hess Reception
- UPDATE: Certolizumab Pegol, CIMZIA®, receives FDA Breakthrough Therapy Designation for the Prevention of Adverse Pregnancy Outcomes in Women with Antiphospholipid Syndrome and Lupus Anticoagulant
- Lupus Foundation of America Showcases New Research Advancing Lupus Diagnosis and Care at American College of Rheumatology Convergence 2026